InvestorsHub Logo

Blade$dream

09/10/12 7:29 AM

#450 RE: Frankestin #449

.....An upcoming catalyst for Savient, is the Committee for Medicinal Products for Human Use (CHMP) is meeting next month for possible European Union approval for Krystexxa. Approval is expected for Krystexxa in the EU, as there is no currently approved therapy for RCG there. Savient demonstrated good results at the European Union League Against Rheumatism this past June in Berlin.

Louis Ferrari also said in the conference call:

"Right now while you can never predict what these regulatory agencies will or will not do or how quickly they do them, I think that right now we have no reason to think that we won't see an approval by the end of 2012 (in the EU).".....

http://seekingalpha.com/article/825701-buy-savient-pharmaceuticals-for-a-good-momentum-play

Blade$dream

09/10/12 7:29 AM

#451 RE: Frankestin #449

how do you know these dates my friend? tia

Blade$dream

09/15/12 10:45 AM

#464 RE: Frankestin #449

CHMP meetings at front of door :)))